Pulse wave velocity is related to exercise blood pressure response in young adults. The Cardiovascular Risk in Young Finns Study

2020 ◽  
Vol 29 (4) ◽  
pp. 256-263
Author(s):  
Atte Haarala ◽  
Emilia Kähönen ◽  
Teemu Koivistoinen ◽  
Kristiina Pälve ◽  
Janne Hulkkonen ◽  
...  
2011 ◽  
Vol 214 (1) ◽  
pp. 220-224 ◽  
Author(s):  
Teemu Koivistoinen ◽  
Nina Hutri-Kähönen ◽  
Markus Juonala ◽  
Tiit Kööbi ◽  
Heikki Aatola ◽  
...  

2018 ◽  
Vol 3 (5) ◽  
pp. 27-32
Author(s):  
O. V. Fedorishina ◽  
K. V. Protasov ◽  
A. M. Torunova

Background.Little is known about the effect of statins addition to standard antihypertensive therapy on blood pressure level and vascular stiffness in high-risk hypertensive patients.The aimof the study was to assess the dynamics of vascular stiffness in hypertensive patients of high or very high cardiovascular risk under the influence of rosuvastatin addition to combined two-component amlodipine and lisinopril antihypertensive therapy.Materials and methods.We investigated 60 hypertensive patients who were randomized into two groups: the 1st group received a fixed amlodipine/lisinopril combination, the 2nd one followed the same regimen of therapy with addition of 20 mg rosuvastatin. Mean office and ambulatory blood pressure as well as central aortic blood pressure and pulse wave velocity were evaluated in both groups before and after 24-week follow-up period.Results.At end of follow-up period the office and average daily blood pressure significantly decreased in both groups, with more prominent office diastolic blood pressure decline in the 2nd one. The central aortic blood pressure equally decreased in both groups. The augmentation index significantly reduced in both groups, mostly in the 2nd one. The carotid-femoral pulse wave velocity declined in both groups to the same extent. The carotid-radial pulse wave velocity decreased statistically only in the second group.Conclusions.Addition of rosuvastatin to a fixed amlodipine/lisinopril combination in high/very high cardiovascular risk hypertensive patients was accompanied by more pronounced decline of diastolic blood pressure and augmentation index, as well as significantly reduction of pulse wave velocity.


2015 ◽  
Vol 9 (4) ◽  
pp. e38
Author(s):  
Andrea A. Brandao ◽  
Rafael A. Faria ◽  
Roberto Pozzan ◽  
Annelise G. Paiva ◽  
Maria Eliane C. Magalhaes ◽  
...  

2015 ◽  
Vol 9 (4) ◽  
pp. e30
Author(s):  
Rafael A. Faria ◽  
Annelise G. Paiva ◽  
Roberto Pozzan ◽  
Maria Eliane C. Magalhaes ◽  
Erika Maria G. Campana ◽  
...  

Hypertension ◽  
2018 ◽  
Vol 71 (3) ◽  
pp. 451-456 ◽  
Author(s):  
Teemu Koivistoinen ◽  
Leo-Pekka Lyytikäinen ◽  
Heikki Aatola ◽  
Tiina Luukkaala ◽  
Markus Juonala ◽  
...  

Hypertension ◽  
2021 ◽  
Vol 77 (1) ◽  
pp. 193-201
Author(s):  
Alastair J.S. Webb ◽  
Amy Lawson ◽  
Karolina Wartolowska ◽  
Sara Mazzucco ◽  
Peter M. Rothwell

Beat-to-beat variability in blood pressure (BP) is associated with recurrent stroke despite good control of hypertension. However, no study has identified rates of progression of beat-to-beat BP variability (BPV), its determinants, or which patient groups are particularly affected, limiting understanding of its potential as a treatment target. In consecutive patients one month after a transient ischaemic attack or nondisabling stroke (Oxford Vascular Study), continuous noninvasive BP was measured beat-to-beat over 5 minutes (Finometer). Arterial stiffness was measured by carotid-femoral pulse wave velocity (Sphygmocor). Repeat assessments were performed at the 5-year follow-up visit and agreement determined by intraclass correlation coefficient. Rates of progression of systolic BPV (SBPV) and diastolic BPV (DBPV) and their determinants were estimated by mixed-effect linear models, adjusted for age, sex, and cardiovascular risk factors. One hundred eighty-eight of 310 surviving, eligible patients had repeat assessments after a median of 5.8 years. Pulse wave velocity was highly reproducible but SBPV and DBPV were not (intraclass correlation coefficient: 0.71, 0.10, and 0.16, respectively), however, all 3 progressed significantly (pulse wave velocity, 2.39%, P <0.0001; SBPV, 8.36%, P <0.0001; DBPV, 9.7, P <0.0001). Rate of progression of pulse wave velocity, SBPV, and DBPV all increased significantly with age ( P <0.0001), with an increasingly positive skew and were particularly associated with female sex (pulse wave velocity P =0.00035; SBPV P <0.0001; DBPV P <0.0001) and aortic mean SBP (SBPV P =0.037, DBPV P <0.0001). Beat-to-beat BP variability progresses significantly in high-risk patients, particularly in older individuals with elevated aortic systolic pressure. Beat-to-beat BPV and its progression represent potential new therapeutic targets to reduce cardiovascular risk.


Sign in / Sign up

Export Citation Format

Share Document